or Try an Advanced Search...

    Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    A 59.80 0.05% 0.03
    LBPH closed down 0.12 percent on Wednesday, November 20, 2024, on 37 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Up Up Flat
    Historical LBPH trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing High Bullish 1.22%
    New Uptrend Bullish 1.22%
    Pocket Pivot Bullish Swing Setup 1.22%
    Calm After Storm Range Contraction 1.22%
    NR7 Range Contraction 1.22%
    NR7-2 Range Contraction 1.22%
    Narrow Range Bar Range Contraction 1.22%
    Parabolic Rise Strength 1.22%
    Stochastic Reached Overbought Strength 1.22%
    Upper Bollinger Band Walk Strength 1.22%
    Older End-of-Day Signals for LBPH ...

       Recent Intraday Alerts

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    LBPH Chart by TradingView
    Basic chart:

    Profile

    Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Neuroscience Psychiatry Epilepsy Amyotrophic Lateral Sclerosis Neurophysiology Neurology Nervous System Clinical Trial Product Neurological Diseases

    Is LBPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Longboard commences Phase III trial of bexicaserin for DEEs seizure treatment
    Nov 12 Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
    Nov 8 Longboard Pharmaceuticals GAAP EPS of -$0.63
    Nov 7 Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
    Nov 6 Longboard Pharmaceuticals HSR waiting period expires for Lundbeck deal
    Oct 20 Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio?
    Oct 15 Health Care Roundup: Market Talk
    Oct 15 Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52%
    Oct 15 Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management
    Oct 15 Lundbeck to acquire Longboard Pharmaceuticals for $2.6bn
    See more LBPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 59.95
    52 Week Low 3.6
    Average Volume 2,005,014
    200-Day Moving Average 30.89
    50-Day Moving Average 48.07
    20-Day Moving Average 59.71
    10-Day Moving Average 59.77
    Average True Range 0.76
    RSI (14) 78.72
    ADX 55.71
    +DI 46.56
    -DI 13.82
    Chandelier Exit (Long, 3 ATRs) 57.68
    Chandelier Exit (Short, 3 ATRs) 61.09
    Upper Bollinger Bands 59.88
    Lower Bollinger Band 59.53
    Percent B (%b) 0.68
    BandWidth 0.59
    MACD Line 2.78
    MACD Signal Line 3.64
    MACD Histogram -0.8682
    Fundamentals Value
    Market Cap 1.97 Billion
    Num Shares 32.9 Million
    EPS -2.43
    Price-to-Earnings (P/E) Ratio -24.60
    Price-to-Sales 0.00
    Price-to-Book 13.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 59.88
    Resistance 3 (R3) 59.89 59.86 59.86
    Resistance 2 (R2) 59.86 59.83 59.85 59.86
    Resistance 1 (R1) 59.81 59.81 59.81 59.81 59.85
    Pivot Point 59.78 59.78 59.78 59.78 59.78
    Support 1 (S1) 59.74 59.75 59.73 59.73 59.69
    Support 2 (S2) 59.71 59.74 59.70 59.68
    Support 3 (S3) 59.66 59.71 59.68
    Support 4 (S4) 59.66